Your browser doesn't support javascript.
loading
Beneficial effects of the combination of BCc1 and Hep-S nanochelating-based medicines on IL-6 in hospitalized moderate COVID-19 adult patients: a randomized, double-blind, placebo-controlled clinical trial.
Hafizi, Maryam; Kalanaky, Somayeh; Fakharzadeh, Saideh; Karimi, Pegah; Fakharian, Atefeh; Lookzadeh, Somayeh; Mortaz, Esmaeil; Mirenayat, Maryam Sadat; Heshmatnia, Jalal; Karam, Mehrdad Bakhshayesh; Zamani, Homa; Nadji, Alireza; Toutkaboni, Mihan Pourabdollah; Oraee-Yazdani, Saeed; Akbari, Mohammad Esmaeil; Jamaati, Hamidreza; Nazaran, Mohammad Hassan.
Afiliação
  • Hafizi M; Department of Research and Development, Sodour Ahrar Shargh Company, Tehran, Iran.
  • Kalanaky S; Department of Research and Development, Sodour Ahrar Shargh Company, Tehran, Iran.
  • Fakharzadeh S; Department of Research and Development, Sodour Ahrar Shargh Company, Tehran, Iran.
  • Karimi P; Department of Research and Development, Sodour Ahrar Shargh Company, Tehran, Iran.
  • Fakharian A; Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Lookzadeh S; Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Mortaz E; Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Mirenayat MS; Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Heshmatnia J; Chronic Respiratory Diseases Research Center (CRDRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Karam MB; Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Zamani H; Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Nadji A; Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Toutkaboni MP; Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Oraee-Yazdani S; Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Akbari ME; Functional Neurosurgery Research Center, Comprehensive Neurosurgical Center of Excellence, Shohada Tajrish, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Jamaati H; Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. crc@sbmu.ac.ir.
  • Nazaran MH; Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran. hamidjamaati@hotmail.com.
Trials ; 24(1): 720, 2023 Nov 11.
Article em En | MEDLINE | ID: mdl-37951972
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Selênio / COVID-19 Limite: Adult / Humans País/Região como assunto: Asia Idioma: En Revista: Trials Assunto da revista: MEDICINA / TERAPEUTICA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Irã
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Selênio / COVID-19 Limite: Adult / Humans País/Região como assunto: Asia Idioma: En Revista: Trials Assunto da revista: MEDICINA / TERAPEUTICA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Irã